Literature DB >> 3301409

Binding of low-density lipoprotein to monolayer cultures of rat hepatocytes is increased by insulin and decreased by dexamethasone.

A M Salter, S C Fisher, D N Brindley.   

Abstract

Rat hepatocytes were maintained in monolayer culture for 20 h in the presence of 10% (v/v) newborn calf serum and then for a further 1-24 h in serum-free medium containing 2 g bovine serum albumin/l. The specific binding of human 125I-LDL to two distinct sites was then measured at 4 degrees C. Binding to site 1 was displaced by dextran sulphate while that to site 2 was not. The presence of 1-100 nM insulin for 24 h in the second incubation significantly increased binding to site 1. Significant increases were also seen when cells were incubated with 10 nM insulin for 1 h. No significant effects of insulin on binding to site 2 were observed. In contrast, 10 nM-1 microM dexamethasone decreased binding to both sites. The effects of these hormones were mutually antagonistic.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3301409     DOI: 10.1016/0014-5793(87)80895-5

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Modeling of corticosteroid effects on hepatic low-density lipoprotein receptors and plasma lipid dynamics in rats.

Authors:  Anasuya Hazra; Nancy A Pyszczynski; Debra C DuBois; Richard R Almon; William J Jusko
Journal:  Pharm Res       Date:  2007-08-03       Impact factor: 4.200

Review 2.  Modulation of insulin action by vanadate: evidence of a role for phosphotyrosine phosphatase activity to alter cellular signaling.

Authors:  I G Fantus; G Deragon; R Lai; S Tang
Journal:  Mol Cell Biochem       Date:  1995 Dec 6-20       Impact factor: 3.396

3.  Stimulation of apolipoprotein secretion in very-low-density and high-density lipoproteins from cultured rat hepatocytes by dexamethasone.

Authors:  P Martin-Sanz; J E Vance; D N Brindley
Journal:  Biochem J       Date:  1990-11-01       Impact factor: 3.857

4.  Glucagon, cyclic AMP and adrenaline stimulate the degradation of low-density lipoprotein by cultured rat hepatocytes.

Authors:  N F Brown; A M Salter; R Fears; D N Brindley
Journal:  Biochem J       Date:  1989-09-01       Impact factor: 3.857

5.  Evidence for sterol-independent regulation of low-density lipoprotein receptor activity in Hep-G2 cells.

Authors:  J L Ellsworth; C Chandrasekaran; A D Cooper
Journal:  Biochem J       Date:  1991-10-01       Impact factor: 3.857

6.  Biphasic effects of glucagon and cyclic AMP on the synthesis and secretion of lipids by rat hepatocytes.

Authors:  D Hermier; P Hales; D N Brindley
Journal:  Biochem J       Date:  1991-11-01       Impact factor: 3.857

7.  Circadian rhythm in hepatic low-density-lipoprotein (LDL)-receptor expression and plasma LDL levels.

Authors:  S Balasubramaniam; A Szanto; P D Roach
Journal:  Biochem J       Date:  1994-02-15       Impact factor: 3.857

8.  Increased plasma triglyceride secretion in EFA-deficient rats fed diets with or without saturated fat.

Authors:  M A Williams; J Tinoco; I Hincenbergs; B Thomas
Journal:  Lipids       Date:  1989-05       Impact factor: 1.880

Review 9.  The biochemistry of lipoproteins.

Authors:  A M Salter; D N Brindley
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

10.  Lipid levels are associated with a regulatory polymorphism of the monoamine oxidase-A gene promoter (MAOA-uVNTR).

Authors:  Beverly H Brummett; Stephen H Boyle; Ilene C Siegler; Stephan Zuchner; Allison Ashley-Koch; Redford B Williams
Journal:  Med Sci Monit       Date:  2008-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.